Shares of Brainstorm Cell Therapeutics Inc. (Nasdaq: BCLI) extended its gains by leaping $2.74 to close at $7.50.
Brainstorm Cell Therapeutics extends gains
January 02, 2015 at 16:35 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.